Trials / Unknown
UnknownNCT04256096
Randomization of Endovascular Treatment in Acute Ischemic Stroke in the Extended Time Window
Randomization of Endovascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke Due to Large VEssel OcclusioN Trial in the Extended Time Window
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 376 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A phase III, randomized, multi-center, open label clinical trial that will examine whether endovascular treatment is superior to standard medical therapy alone in patients who suffer a large vessel anterior circulation ischemic stroke within 8-24 hours from time last seen well
Detailed description
Prospective, multi-center, randomized, controlled, open-label, blinded-endpoint trial with a sequential design. The randomization employs a 1:1 ratio of mechanical thrombectomy with stent-retriever and/or thromboaspiration versus medical management alone in patients who suffer a large vessel anterior circulation ischemic stroke between 8 and 24 hours from time last seen well. Randomization will be done under a minimization process using age (≤68 vs. \>68 years), baseline NIHSS (\<17 v. ≥17), ASPECTS (5-7 vs. 8-10), therapeutic window (6-12 or 12-24 hours after TLKW), occlusion site (Intracranial ICA or M1), and clinical site. For the primary endpoint, subjects will be followed for 90 days post-randomization. Sham endovascular procedure has been rejected due to the medical risk of the angiography and practical issues that difficult to maintain blindness of investigators.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Thrombectomy | Endovascular treatment of large vessel occlusion (mechanical thrombectomy) with stent-retriever and/or thromboaspiration (neurointerventionalist choice) |
Timeline
- Start date
- 2020-03-09
- Primary completion
- 2022-02-01
- Completion
- 2022-05-01
- First posted
- 2020-02-05
- Last updated
- 2021-02-10
Locations
14 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT04256096. Inclusion in this directory is not an endorsement.